Fayez Sarofim & CO Portfolio Holdings

Fayez Sarofim & CO

  • $38.7 Billion
  • Q3 2024

Fayez Sarofim & CO has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $38.7 Billion distributed in 534 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $3.91B, Microsoft Corp with a value of $3.48B, Amazon Com Inc with a value of $1.48B, Novo Nordisk A S with a value of $1.45B, and Coca Cola CO with a value of $1.24B.

Examining the 13F form we can see an increase of $2.21B in the current position value, from $36.5B to 38.7B.

Fayez Sarofim & CO is based out at Houston, TX

Below you can find more details about Fayez Sarofim & CO portfolio as well as his latest detailed transactions.

Portfolio value $38.7 Billion
Technology: $11.2 Billion
Financial Services: $7.08 Billion
Healthcare: $5.17 Billion
Consumer Defensive: $4.61 Billion
Energy: $3.4 Billion
Consumer Cyclical: $2.97 Billion
Communication Services: $1.89 Billion
Industrials: $1.81 Billion
Other: $590 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$49B
$961,000 0.0% of portfolio
7,122
Q3 2024 Reduced 15.37%
$0
$657,000 0.0% of portfolio
12,444
Q4 2021 New
$0
$466,000 0.0% of portfolio
884
Q3 2024 Reduced 4.64%
$136B
$317,000 0.0% of portfolio
3,793
Q3 2024 Reduced 70.18%
$159B
$502,000 0.0% of portfolio
11,184
Q1 2024 Added 6.51%
$188B
$1.06 Million 0.0% of portfolio
251
Q3 2024 Reduced 2.33%
$179M
$404,000 0.0% of portfolio
9,719
Q3 2024 Added 12.5%
$21.4B
$445,000 0.0% of portfolio
2,300
Q2 2023 Reduced 68.97%
Wk Kellogg CO
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.93%
$66.6B
$373,000 0.0% of portfolio
1,551
Q2 2024 Reduced 31.1%
$10.2B
$1.37 Million 0.0% of portfolio
152,679
Q3 2024 Reduced 1.03%
$85.1B
$1.49 Million 0.0% of portfolio
7,187
Q2 2024 Reduced 5.92%
$3.46B
$220,000 0.0% of portfolio
8,800
Q2 2024 New
$21.7B
$780,000 0.0% of portfolio
7,065
Q1 2023 Added 7.62%
$4.68B
$836,000 0.0% of portfolio
16,347
Q2 2024 Reduced 12.29%
$24.5B
$480,000 0.0% of portfolio
16,540
Q3 2023 Reduced 2.36%
$53.2B
$648,000 0.0% of portfolio
624
Q2 2024 Reduced 13.81%
$48.7B
$925,000 0.0% of portfolio
20,814
Q3 2023 New
$191B
$1.24 Million 0.0% of portfolio
2,496
Q3 2024 Added 66.73%
$56.3B
$460,000 0.0% of portfolio
15,593
Q2 2023 Reduced 13.02%
$104B
$323,000 0.0% of portfolio
1,450
Q4 2023 Reduced 10.16%
$16.4B
$524,000 0.0% of portfolio
3,754
Q1 2024 Reduced 9.32%
$31.7B
$902,000 0.0% of portfolio
1,677
Q3 2024 Reduced 28.18%
$97.5B
$520,000 0.0% of portfolio
7,211
Q2 2024 Reduced 0.14%
$70.8B
$384,000 0.0% of portfolio
8,584
Q3 2024 New
$34.7B
$1.06 Million 0.0% of portfolio
14,415
Q3 2024 Reduced 3.35%
$188B
$1.24 Million 0.0% of portfolio
6,565
Q2 2024 Added 3.14%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.58%
$108B
$422,000 0.0% of portfolio
4,078
Q3 2023 New
$6.22B
$1.24 Million 0.0% of portfolio
10,097
Q2 2023 Reduced 50.0%
$65.1B
$307,000 0.0% of portfolio
1,336
Q2 2024 Reduced 0.15%
$16.8B
$403,000 0.0% of portfolio
2,893
Q3 2024 New
$4.43B
$1.3 Million 0.0% of portfolio
10,000
Q3 2017 New
$29.4B
$484,000 0.0% of portfolio
4,080
Q3 2024 Reduced 13.5%
$0
$246,000 0.0% of portfolio
427
Q3 2024 Added 1.91%
$0
$222,000 0.0% of portfolio
1,896
Q2 2024 Reduced 39.0%
$0
$430,000 0.0% of portfolio
4,680
Q4 2020 Added 300.0%
$0
$204,000 0.0% of portfolio
651
Q3 2024 New
$0
$259,000 0.0% of portfolio
914
Q3 2023 Reduced 13.04%
$0
$309,000 0.0% of portfolio
1,403
Q2 2024 New
$0
$254,000 0.0% of portfolio
2,060
Q4 2022 New
$0
$350,000 0.0% of portfolio
2,996
Q4 2023 Reduced 3.42%
$34.8B
$1.33 Million 0.0% of portfolio
2,629
Q2 2024 Added 8.23%
$34B
$570,000 0.0% of portfolio
1,800
Q4 2023 Added 63.64%
$96.8B
$516,000 0.0% of portfolio
667
Q1 2024 Added 35.57%
Howard Hughes Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Kenvue Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 29.83%
$83B
$569,000 0.0% of portfolio
1,200
Q4 2023 Reduced 6.61%
$76B
$517,000 0.0% of portfolio
1,151
Q3 2024 Reduced 7.99%

Summary

  • Portfolio
  • No. of Stocks 534
  • Current Value $38.7 Billion
  • Prior Value $36.5 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 14 stocks
  • Additional Purchases 89 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 78 stocks
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email